Besides, since CDK5 is a target present in nerves, the neurological side effects of concern can be minimised through a strategy that prevents the passage of the blood-brain barrier, and a study of CDK5 therapy in carcinomas where nerves are involved in the growth and progression of cancer. Here, CDK5 is linked to carcinoma.